Raymond James Financial Services Advisors, Inc. Compugen LTD Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$2.76 - $4.64 $88,734 - $149,176	-32,150 Reduced 73.1%	11,831 $38,000
Q4 2021 Feb 08, 2022	SELL	$4.09 - $7.16 $25,627 - $44,864	-6,266 Reduced 12.47%	43,981 $189,000
Q3 2021 Nov 02, 2021	SELL	$5.8 - $8.02 $20,073 - $27,757	-3,461 Reduced 6.44%	50,247 $300,000
Q2 2021 Aug 11, 2021	SELL	$6.87 - $9.16 $244,242 - $325,656	-35,552 Reduced 39.83%	53,708 $445,000
Q1 2021 May 14, 2021	BUY	$7.67 - $13.77 $229,777 - $412,521	29,958 Added 50.52%	89,260 $767,000
Q4 2020 Feb 12, 2021	BUY	$12.07 - $17.95 $158,744 - $236,078	13,152 Added 28.5%	59,302 $718,000
Q3 2020 Nov 04, 2020	BUY	$14.16 - $19.45 $4,063 - $5,582	287 Added 0.63%	46,150 $750,000
Q2 2020 Jul 17, 2020	BUY	$6.97 - $17.12 $33,142 - $81,405	4,755 Added 11.57%	45,863 $689,000
Q1 2020 Apr 21, 2020	BUY	$5.79 - $11.83 $28,411 - $58,049	4,907 Added 13.55%	41,108 $298,000
Q3 2019 Nov 07, 2019	BUY	$3.01 - $4.49 $30,099 - $44,900	10,000 Added 38.17%	36,201 $153,000
Q1 2019 May 06, 2019	BUY	$2.35 - $4.19 $25,850 - $46,090	11,000 Added 72.36%	26,201 $108,000
Q4 2018 Feb 11, 2019	BUY	$2.17 - $3.8 $420 - $737	194 Added 1.29%	15,201 $33,000
Q3 2018 Nov 14, 2018	BUY	$3.0 - $4.05 $45,021 - $60,778	15,007 New	15,007 $58,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.3M

Call Options Held

191K

Put Options Held

135K

Silverarc Capital Management, LLC

1.5M
Shares

$2.46 Million
0.72% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.29M
Shares

$2.11 Million
0.0% of portfolio
Taylor Frigon Capital Management LLC

1.2M
Shares

$1.97 Million
1.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

1.09M
Shares

$1.79 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

1.02M
Shares

$1.67 Million
0.0% of portfolio

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account